Agenda Released for Superbugs USA: PAHO/WHO, NIH, AstraZeneca, Pfizer and BARDA Present This Autumn

SMi announce that a brochure has been released for Superbugs & Superdrugs USA, taking place on November 14th & 15th 2016 in Iselin, New Jersey.
By: SMi Group
 
 
Brochure for Superbugs & Superdrugs USA
Brochure for Superbugs & Superdrugs USA
July 12, 2016 - PRLog -- SMi are thrilled to announce the release of the highly anticipated brochure for Superbugs & Superdrugs USA taking place on November 14th & 15th 2016 in Iselin, New Jersey.

Aiming to provide solutions in funding drug development projects, as well as guidance on antibiotic alternatives and updates on global initiatives to fight infectious diseases, the agenda will look to arm attendees with an effective toolkit of ideas to fight the global attack against bacteria's defensive walls.

The notable speaker line-up will feature:

Dr Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
Dr Christopher Houchens, Branch Chief, Antibacterials Program, BARDA
Dr Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
Dr John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer
Dr Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
Dr Mahesh Kumar, Vice President, Global Biological Research and Development, Zoetis

Event highlights will include:

1.       HOST NATION KEYNOTES: Leading government bodies will provide progress in the development of National Action Plans with case study insight into new paradigms for prevention.

2.       CURRENT STATUS: Progressive insight will be given into innovative developments in big pharma with updates on drug discovery and antibiotic sensitivity in multi-drug resistance infections.

3.       FAST TO MARKET: Delegates will evaluate zoonotic links between animals and humans to target emerging infectious diseases.

4.       DRUG DISCOVERY: The programme will address antibiotic drug development through novel approaches in treating gram-negative infections.

A full speaker line-up and detailed conference agenda is available to download online at http://www.smi-online.co.uk/pharmaceuticals/northamerica/superbugs-superdrugs-usa. For those looking to attend, there is currently a $400 discount available which expires on July 15th 2016.

Superbugs & Superdrugs USA
The Global Attack Against Bacteria's Defensive Walls
November 14th & 15th 2016
Renaissance Woodbridge Hotel, Iselin, New Jersey
Sponsored by Polyphor
http://www.smi-online.co.uk/pharmaceuticals/northamerica/superbugs-superdrugs-usa

Contact Information:

For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk

To register for the conference, visit http://www.smi-online.co.uk/pharmaceuticals/northamerica/superbugs-superdrugs-usa or contact Matthew Apps on Tel: +44 (0)20 7827 6093 / Email: mapps@smi-online.co.uk

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Contact
Teri Arri
***@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Superbug, Antibiotic, Antimicrobial Resistance
Industry:Health
Location:England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jul 12, 2016
SMi Group Ltd. PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share